PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma von Nghiem, Paul T, Bhatia, Shailender, Lipson, Evan J, Kudchadkar, Ragini R, Miller, Natalie J, Annamalai, Lakshmanan, Berry, Sneha, Chartash, Elliot K, Daud, Adil, Fling, Steven P, Friedlander, Philip A, Kluger, Harriet M, Kohrt, Holbrook E, Lundgren, Lisa, Margolin, Kim, Mitchell, Alan, Olencki, Thomas, Pardoll, Drew M, Reddy, Sunil A, Shantha, Erica M, Sharfman, William H, Sharon, Elad, Shemanski, Lynn R, Shinohara, Michi M, Sunshine, Joel C, Taube, Janis M, Thompson, John A, Townson, Steven M, Yearley, Jennifer H, Topalian, Suzanne L, Cheever, Martin A

Volltext

Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving co... von Weisman, Michael H., Moreland, Larry W., Furst, Daniel E., Weinblatt, Michael E., Keystone, Edward C., Paulus, Harold E., Teoh, Leah S., Velagapudi, Raja B., Noertersheuser, Peter A., Granneman, G.Richard, Fischkoff, Steven A., Chartash, Elliot K.

Volltext

Safety and Efficacy of ABT-874, a Fully Human Interleukin 12/23 Monoclonal Antibody, in the Treatment of Moderate to Severe Chronic Plaque Psoriasis von Kimball, Alexa B, Gordon, Kenneth B, Langley, Richard G, Menter, Alan, Chartash, Elliot K, Valdes, Joaquin

Volltext

Safety and Efficacy of ABT-874, a Fully Human Interleukin 12/23 Monoclonal Antibody, in the Treatment of Moderate to Severe Chronic Plaque Psoriasis: Results of a Randomized, Place... von Kimball, Alexa B, Gordon, Kenneth B, Langley, Richard G, Menter, Alan, Chartash, Elliot K, Valdes, Joaquin

Volltext

Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti–tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis r... von Keystone, Edward C., Kavanaugh, Arthur F., Sharp, John T., Tannenbaum, Hyman, Hua, Ye, Teoh, Leah S., Fischkoff, Steven A., Chartash, Elliot K.

Volltext

Adalimumab, a fully human anti–tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trial... von Weinblatt, Michael E., Keystone, Edward C., Furst, Daniel E., Moreland, Larry W., Weisman, Michael H., Birbara, Charles A., Teoh, Leah A., Fischkoff, Steven A., Chartash, Elliot K.

Volltext

Adalimumab plus methotrexate or standard therapy is more effective than methotrexate or standard therapies alone in the treatment of fatigue in patients with active, inadequately t... von YOUNT, S, SORENSEN, M. V, CELLA, D, SENGUPTA, N, GROBER, J, CHARTASH, E. K

Volltext

Clonal expansion is a characteristic feature of the B-cell repertoire of patients with rheumatoid arthritis von Itoh, Kenji, Patki, Varsha, Furie, Richard A, Chartash, Elliot K, Jain, Rita I, Lane, Lewis, Asnis, Stanley E, Chiorazzi, Nicholas

Volltext

Cardiac manifestations of the antiphospholipid syndrome von Kaplan, Stuart D., Chartash, Elliot K., Pizzarello, Roy A., Furie, Richard A.

Volltext

Adalimumab, a fully human anti-tumor necrosis factor a monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trial von WEINBLATT, Michael E, KEYSTONE, Edward C, FURST, Daniel E, MORELAND, Larry W, WEISMAN, Michael H, BIRBARA, Charles A, TEOH, Leah A, FISCHKOFF, Steven A, CHARTASH, Elliot K

Volltext

COMBINATION THERAPY OF A PD-1 ANTAGONIST AND LAG3 ANTAGONIST FOR TREATING PATIENTS WITH NON-MICROSATELLITE INSTABILITY-HIGH OR PROFICIENT MISMATCH REPAIR COLORECTAL CANCER von Chartash, Elliot K, McClanahan, Terrill K, Healy, Jane Anne

Volltext bestellen

DOSING REGIMEN OF ANTI-CD27 ANTIBODIES FOR TREATMENT OF CANCER von Cheung, Jason K, Li, Claire H, Chartash, Elliot K, Wnek, Richard, Beebe, Amy M, Dobrenkov, Konstantin

Volltext bestellen

Combination of PD-1 antagonist and LAG3 antagonist for treating non-microsatellite instablity-high/proficient mismatch repair colorectal cancer von MCCLANAHAN, Terrill K, CHARTASH, Elliot K, HEALY, Jane Anne

Volltext bestellen

MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNFALPHA-RELATED DISORDERS von Granneman, George R, Chartash, Elliot K, Hoffman, Rebecca S, Yan, Philip, Taylor, Lori K

Volltext bestellen

DOSING REGIMEN OF ANTI-LAG3 ANTIBODY AND COMBINATION THERAPY WITH ANTI-PD-1 ANTIBODY FOR TREATING CANCER von LEVITAN, Diane, CHARTASH, Elliot, K, ZHAO, Qing, GARRIDO, Rosario, JUCO, Jonathan, W, HEALY, Jane Anne, ABRAHAM, Anson Kunjachan, EMANCIPATOR, Kenneth

Volltext bestellen

Aortic insufficiency and mitral regurgitation in patients with systemic lupus erythematosus and the antiphospholipid syndrome von Chartash, Elliot K., Lans, David M., Paget, Stephen A., Qamar, Tasneem, Lockshin, Michael D.

Volltext

DOSING REGIMEN OF ANTI-LAG3 ANTIBODY AND COMBINATION THERAPY WITH ANTI-PD-1 ANTIBODY FOR TREATING CANCER von Levitan, Diane, Emancipator, Kenneth, Garrido, Rosario, Chartash, Elliot K, Juco, Jonathan W, Healy, Jane Anne, Abraham, Anson Kunjachan, Zhao, Qing

Volltext bestellen

DOSING REGIMEN OF ANTI-LAG3 ANTIBODY AND COMBINATION THERAPY WITH ANTI-PD-1 ANTIBODY FOR TREATING CANCER von LEVITAN, Diane, CHARTASH, Elliot, K, ZHAO, Qing, GARRIDO, Rosario, JUCO, Jonathan, W, HEALY, Jane Anne, ABRAHAM, Anson Kunjachan, EMANCIPATOR, Kenneth

Volltext bestellen